TY  - GEN 
AU  - Bustos, Antonio
AU  - Selvi Sabater, Pablo
AU  - Benlloch, María
AU  - Drehmer, Eraci
AU  - López-Rodríguez, María Mar
AU  - Platero, Felix
AU  - Platero, Jose Luis
AU  - Escribá-Alepuz, Jesús
AU  - Rubia Ortí, Jose Enrique de la
PY  - 2021
SN  - 1010-660X,
UR  - http://hdl.handle.net/10835/9523
AB  - Background and objectives: The aim of this study was to report a case of a patient with Charcot-Marie-Tooth disease type 2 (CMT2) treated with epigallocatechin gallate (EGCG) for 4 months in order to assess its therapeutic potential in CMT2. Materials...
LA  - cat
PB  - MDPI
KW  - Charcot-Marie-Tooth disease type 2
KW  - epigallocatechin gallate
KW  - IL-6
KW  - motor activity
KW  - paraoxonase 1
TI  - Metabolic and Functional Improvements in a Patient with Charcot-Marie-Tooth Disease Type 2 after EGCG Administration: A Case Report
ER  -